Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.

Chotpitayasunondh T, Thisyakorn U, Pancharoen C, Pepin S, Nougarede N.

PLoS One. 2008;3(12):e4028. doi: 10.1371/journal.pone.0004028. Epub 2008 Dec 29.

3.

Aflunov(®): a prepandemic influenza vaccine.

Gasparini R, Amicizia D, Lai PL, Panatto D.

Expert Rev Vaccines. 2012 Feb;11(2):145-57. doi: 10.1586/erv.11.170. Review.

PMID:
22309663
4.

The avian influenza vaccine Emerflu. Why did it fail?

Young BE, Sadarangani SP, Leo YS.

Expert Rev Vaccines. 2015;14(8):1125-34. doi: 10.1586/14760584.2015.1059760. Epub 2015 Jun 22. Review.

PMID:
26098721
5.

Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.

Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P.

Lancet Infect Dis. 2009 Aug;9(8):482-92. doi: 10.1016/S1473-3099(09)70153-7. Review.

PMID:
19628173
6.

Safety and immunogenicity of Sinovac's prototype pandemic influenza H5N1 vaccines: a review on clinical trials.

Qiu YZ, Yin WD.

Influenza Other Respir Viruses. 2008 Nov;2(6):237-42. doi: 10.1111/j.1750-2659.2008.00067.x. Review.

7.

Aluminium-adjuvanted vaccines--a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(4):731-4, 871-4. Review. English, Polish.

8.

Vaccination in the elderly.

Derhovanessian E, Pawelec G.

Microb Biotechnol. 2012 Mar;5(2):226-32. doi: 10.1111/j.1751-7915.2011.00283.x. Epub 2011 Aug 31. Review.

Items per page

Supplemental Content

Write to the Help Desk